Search Press releases

Press releases teaser image
29 Nov 2024

UCB Focuses on New Launch and Completes Divestment of Mature Product Business in China

Read More
Press releases teaser image
27 Nov 2024

UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting

Read More
Press releases teaser image
20 Nov 2024

UCB receives U.S. FDA approval for BIMZELX[®] (bimekizumab-bkzx) as the first IL-17A and IL-17F inhibitor for adults with moderate to severe hidradenitis suppurativa

Read More
Press releases teaser image
19 Nov 2024

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Read More
Press releases teaser image
18 Nov 2024

Transparency notification BlackRock, Inc.

Read More
Press releases teaser image
18 Nov 2024

Transparency notification BlackRock, Inc.

Read More

Stay up-to-date on the latest news and information from UCB